Gagnon Advisors, LLC - Q2 2019 holdings

$175 Million is the total value of Gagnon Advisors, LLC's 33 reported holdings in Q2 2019. The portfolio turnover from Q1 2019 to Q2 2019 was 6.1% .

 Value Shares↓ Weighting
EVBG  EVERBRIDGE INC$11,097,000
+19.2%
124,1000.0%6.34%
+18.9%
CDNA SellCAREDX INC$10,573,000
-8.2%
293,785
-19.6%
6.04%
-8.4%
AL  AIR LEASE CORPcl a$10,540,000
+20.3%
254,9500.0%6.02%
+20.1%
AMRC  AMERESCO INCcla$9,323,000
-9.0%
632,9520.0%5.32%
-9.2%
EQIX  EQUINIX INC$7,687,000
+11.3%
15,2440.0%4.39%
+11.0%
RTEC  RUDOLPH TECHNOLOGIES INC$7,462,000
+21.2%
270,0700.0%4.26%
+20.9%
GFN  GENERAL FIN CORP DEL$7,458,000
-10.3%
891,0240.0%4.26%
-10.5%
NEWR  NEW RELIC INC$6,955,000
-12.4%
80,3920.0%3.97%
-12.6%
NVGS BuyNAVIGATOR HOLDINGS LTD$6,551,000
+11.8%
699,871
+31.4%
3.74%
+11.6%
SU  SUNCOR ENERGY INC NEW$6,539,000
-3.9%
209,8610.0%3.73%
-4.1%
BL  BLACKLINE INC$6,444,000
+15.5%
120,4190.0%3.68%
+15.3%
YEXT BuyYEXT INC$6,379,000
+20.4%
317,529
+31.0%
3.64%
+20.1%
CSLT  CASTLIGHT HEALTH INCcl b$6,169,000
-13.9%
1,909,8250.0%3.52%
-14.1%
FIVN BuyFIVE9 INC$5,957,000
+32.8%
116,152
+36.8%
3.40%
+32.5%
INST SellINSTRUCTURE INC$5,649,000
-29.4%
132,921
-21.7%
3.22%
-29.5%
ZUO BuyZUORA INC$5,539,000
+53.2%
361,548
+100.3%
3.16%
+52.8%
FLXN  FLEXION THERAPEUTICS INC$4,940,000
-1.5%
401,6480.0%2.82%
-1.7%
AOSL  ALPHA & OMEGA SEMICONDUCTOR$4,939,000
-18.8%
528,7840.0%2.82%
-19.0%
EPD  ENTERPRISE PRODS PARTNERS L$4,938,000
-0.8%
171,0510.0%2.82%
-1.0%
IRBT  IROBOT CORP$4,781,000
-22.1%
52,1750.0%2.73%
-22.3%
PCRX NewPACIRA BIOSCIENCES$4,671,000107,412
+100.0%
2.67%
SCWX  SECUREWORKS CORPcl a$4,656,000
-27.8%
350,3350.0%2.66%
-27.9%
PSIX BuyPOWER SOLUTIONS INTL INC$4,610,000
+38.1%
472,836
+6.1%
2.63%
+37.8%
WPX  WPX ENERGY INC$3,984,000
-12.2%
346,1440.0%2.27%
-12.4%
LL  LUMBER LIQUIDATORS HLDGS INC$3,618,000
+14.3%
313,2430.0%2.06%
+14.1%
CELC  CELCUITY INC$3,316,000
+14.1%
132,6270.0%1.89%
+13.8%
TLND  TALEND SAads$1,921,000
-23.7%
49,7730.0%1.10%
-23.8%
POEFF BuyPAN ORIENT ENERGY CORP$1,728,000
+69.1%
1,045,355
+45.4%
0.99%
+68.5%
APEN  APOLLO ENDOSURGERY INC$1,689,000
-13.1%
519,8460.0%0.96%
-13.3%
CEMI  CHEMBIO DIAGNOSTICS INC$1,517,000
+9.8%
249,0820.0%0.87%
+9.5%
GFNCP  GENERAL FIN CORP DELseries c preferred$1,372,000
+1.1%
13,3290.0%0.78%
+0.9%
PRFMF  PROFOUND MED CORP$1,104,000
+0.9%
1,826,9250.0%0.63%
+0.6%
CNF  CNFINANCE HLDGS LTDspon ads$1,077,000
-2.2%
181,6330.0%0.62%
-2.4%
AMBR ExitAMBER ROAD INC$0-671,219
-100.0%
-3.33%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2019-08-12
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
AIR LEASE CORPORATION CL A40Q3 20239.0%
AMERESCO INC CL A40Q3 202310.3%
ALPHA & OMEGA SEMICONDUCTOR LTD40Q3 20239.6%
POWER SOLUTIONS INTL INC40Q3 20235.9%
CAREDX INC COM37Q3 202316.7%
EQUINIX INC REIT36Q3 20239.3%
NAVIGATOR HOLDINGS LTDORD SHS34Q3 202310.9%
FIVE9 INC COM USD0.00131Q3 20236.2%
LUMBER LIQUIDATORS HOLDINGSINC31Q3 20226.3%
CASTLIGHT HEALTH INC CL B30Q4 20214.1%

View Gagnon Advisors, LLC's complete holdings history.

Latest filings
TypeFiled
13F-HR2024-02-14
13F-HR2023-11-14
13F-HR2023-08-08
13F-HR2023-04-10
13F-HR2023-02-07
13F-HR2022-11-14
13F-HR2022-08-01
13F-HR2022-05-09
13F-HR2022-02-08
13F-HR2021-11-12

View Gagnon Advisors, LLC's complete filings history.

Compare quarters

Issues

The following issues were detected while analyzing the report:

  • The reported total value is incorrect (175185000.0 != 175183000.0)

Export Gagnon Advisors, LLC's holdings